Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
They want better health care — so they're turning to crypto startups - 2Thyssenkrupp to suspend electrical steel production at French site
- 3Vote In favor of Your #1 Compelling Female Producer
- 4The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- 5Warning for snow and ice extended
- Pick Your Favored kind of books
- Washington resident is infected with a different type of bird flu
- Ukraine proved this drone-killer works. Now, the West is giving it a shot.
- Consumer outlook on UK economy falls to two-year low
- 3D Printers for Specialists
- Find Your Internal Culinary expert: Cooking Strategies and Recipes
- Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail
- Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- Vote In favor of Your Favored Treat
